BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹75 Cr | ₹60 Cr | ₹53 Cr | ₹43 Cr | ₹25 Cr |
What is the latest Operating Profit of BETA DRUGS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹75 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹25 Cr |
How is Operating Profit of BETA DRUGS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹75 Cr | 24.35 | |
| Mar2024 | ₹60 Cr | 12.93 | |
| Mar2023 | ₹53 Cr | 24.43 | |
| Mar2022 | ₹43 Cr | 72.57 | |
| Mar2021 | ₹25 Cr | - | |
Compare Operating Profit of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,428.5 Cr | 4.4% | -5.2% | 15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 4.4% |
-5.2% |
15.6% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses